Enterprise Financial Services Corp (EFSC)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-155
Closed -$36K 897
2021
Q2
$36K Buy
155
+7
+5% +$1.25K 0.01% 453
2021
Q1
$20K Sell
148
-159
-52% -$23K ﹤0.01% 595
2020
Q4
$32K Sell
307
-193
-39% -$19.5K 0.01% 473
2020
Q3
$35K Sell
500
-44
-8% -$3.07K 0.01% 446
2020
Q2
$35K Buy
544
+519
+2,076% +$28.4K 0.01% 439
2020
Q1
$1K Buy
+25
New +$575 ﹤0.01% 1178

Other funds holding MRNA

Enterprise Financial Services Corp (EFSC)'s MRNA Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Moderna (MRNA) in Q3 2021, closing a stake of 155 shares — an estimated $36K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in MRNA in Q1 2020 and held it in 6 quarters. The position peaked at $36K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 155 Moderna shares in Q3 2021, an estimated $36K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Moderna in Q1 2020 and held it in 6 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Moderna position peaked at $36K in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.